Public company, Hollister Biosciences CEO and Tommy Chong Representative Chats with Positive Phil about Business, Cannabis and Entrepreneurship in a HUGE industry.
STOCk SYMBOL ( HOLL :CSE )
PositivePhil.com Inc. and PositiveStocks.com, the premier financial information website for small cap investors, announce a new audio interview airing on iHeart Media, Spotify, Itunes, Google Podcasts, StictherFM, Pandora and on over 300 digital channels.
Carl Sailing Founder and CEO of Hollister Biosciences along with Tommy Chong’s representative ( Danny Keith ) joined Positive Phil and his listeners to chat about Cannabis, Business and Entrepreneurship.
Along with Danny Keith www.cannabisclub.tv
Seasoned business leader with 30+ years of experience. Entrepreneur, CEO, and investor.
As CEO he has led his previous company to be acquired by a publicly traded company. His passion for Medical Cannabis is fueled by the benefits of cannabis in fighting many diseases.
Hollister Biosciences to Manufacture and Distribute Tommy Chong’s Cannabis™ Full Spectrum Elixir 1:1
HOLL Stock Jumps 25% on Earlier News of Planned Tactical Relief JV to Create Tinctures for Veterans with PTSD
The California cannabis industry is the largest in the world, but there is no clear-cut leader in The Golden State. State-wide distribution, from San Diego in the south to the pot mecca of Humboldt in the north, is expensive and difficult to establish. Most producers in the state are opting to instead focus on establishing their brands in a few select regions of the state. One new player in the industry has partnered with a famous cannabis user, activist and influencer to bring a celebrity-branded THC & CBD tincture products to market.
Hollister Biosciences is on the Rise
Established in 2017, Hollister Biosciences (CSE: HOLL) (FRA: HOB) is a cannabis and hemp producer located in Hollister, California, a small farming town just south of the San Francisco Bay Area. The company intends to use vertical integration, statewide distribution and leading brands in high-margin segments of the industry to become a dominant player in The Golden State. Management has decided to focus on developing leading cannabis and hemp brands, as opposed to focusing on retail stores. This strategy should allow them to run a leaner and tighter company that’s not bogged down by the capital requirements of opening their own dispensaries.
VIEW THE STOCK
About Hollister Biosciences Inc
Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.”
A Promising and Lucrative New Partnership
While Tommy Chong gained popularity for portraying a stoner, nowadays he’s much more focused on the medical aspects of cannabis. After the market closed today, it was announced that Hollister Biosciences and Tommy Chong signed a licensing deal allowing Hollister to manufacture and distribute Tommy Chong’s Cannabis™ Full Spectrum Elixer 1:1. The cannabis tincture has an equal ratio of THC to CBD.
“We are honored and excited to be partners with such a legendary and Iconic star as Tommy Chong. Tommy has experienced the medical benefits of cannabis and we are looking forward to working together to launch Tommy Chong’s Cannabis Full Spectrum Elixir into the California Legal Cannabis marketplace,” said Hollister CEO Carl Saling.
Chong is licensing the formula and brand to Hollister, who will manufacture and distribute (via WAYV) the finished product. The two parties anticipate production of around 25,000 units in the first year, with each bottle retailing for $70 allowing Hollister to generate potential revenue of $1,750,000 in the first year. Should the product sell well, expect management to increase production dramatically.
In discussing the new partnership with Hollister, Tommy Chong stated: “I only partner with the best-in-class companies and I am really pleased to have the Hollister Cannabis Co. bring their amazing Tommy Chong’s Cannabis™ Full Spectrum Elixir to the market for me”.
Learn more about Hollister: Website | IR Website
The Positive Phil Podcast Show, a podcast, available on iTunes, Spotify, iHeartRadio, where Positive Phil talks about personal stories, events and engaging interviews; with famous people, celebrities, athletes, authors, spiritual educators, thought leaders, as well as others in the social, business and entertainment industry.
Airing on over 300 digital channels, including iHeart Radio, Spotify, StitcherFm, Google Podcast and published online via RSS feeds globally. (metrics, guests, info)
The show has been around for almost 4 years and is one of the most popular podcast shows on the internet in the business-motivation space.
Professional radio, tv, podcast host and producer from San Diego California. We have a large national following on digital media channels, with our popular podcast and network of shows. Airing on iHeart Media, iTunes, Spotify, Spreaker, Stitcher, PlayerFM and over 200 additional media channels.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.